The trial of a new drug, bexobrutideg, shows promising results for chronic lymphocytic leukemia patients previously treated ...

The findings of the UK-wide study, led by researchers from Leeds, could reshape the way the most common form of leukaemia in ...

The Flair trial found that 94 per cent of patients who received the two targeted drugs were alive with no disease progression ...

The Flair trial saw two targeted cancer drugs perform better than standard chemotherapy, halting disease progression in 94% ...

Personalized drug treatments have outperformed chemotherapy for leukemia patients in a trial led by Leeds researchers. Newly ...